Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C6QQ
|
||||
| Former ID |
DIB016758
|
||||
| Drug Name |
Besipirdine
|
||||
| Synonyms |
Besipirdine hydrochloride; HP-749; P-7480; P86-7480
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Phase 3 | [550094] | ||
| Company |
Hoechst Marion Roussel Inc
|
||||
| Formula |
C16H17N3
|
||||
| Canonical SMILES |
n1(ccc2c1cccc2)N(c1ccncc1)CCC
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-1A adrenergic receptor | Target Info | Antagonist | [534361] | |
| PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.